期刊文献+

香味类香味菌尿路感染合并膀胱重度挛缩的诊治并文献复习 被引量:2

Diagnosis and treatment of urinary tract infection due to Myroides odoratimimus combined with bladder contracture and literature review
原文传递
导出
摘要 目的:探讨香味类香味菌尿路感染合并膀胱重度挛缩的临床、病理特点和诊断、治疗方法。方法:回顾性分析1例香味类香味菌尿路感染合并膀胱重度挛缩患者的临床、病理和实验室检查资料并复习相关文献。患者,男,38岁,因"尿频尿急肉眼血尿1个月余入院",行生化及免疫学检查、彩超、CT、膀胱镜、尿培养、活检组织病理检查、活检物镜检等检查,并给予对症治疗、膀胱水扩张、膀胱黏膜保护剂灌注、抗感染治疗等综合治疗,3个月后随访复查。结果:CT提示膀胱重度挛缩,膀胱壁显著增厚;经尿道膀胱镜检查发现膀胱容量显著减小,膀胱黏膜弥漫呈"白石灰"样改变;显微镜微生物检查发现香味类香味菌活菌体,连续尿培养7次结果均提示:香味类香味菌,并多重耐药。给予综合治疗后,患者临床症状明显好转,膀胱容量接近正常,尿培养结果正常,CT及膀胱镜复查明显好转。结论:膀胱挛缩患者的病因复杂,明确诊断困难,尿培养、膀胱镜结合病理检查可提高诊断率;香味类香味菌感染临床罕见,合并膀胱重度挛缩未见报道,综合治疗可能会收到满意疗效。 Objective:To investigate the clinical and pathological characteristics,diagnosis and treatment of Myroides odoratimimus infection combined with bladder contracture.Method:The clinical,pathological and laboratory data of a case of Myroides odoratimimus urinary tract infection combined with severe contracture of the bladder were retrospectively analyzed and the related literature was reviewed.The male patient whose age was 38 years old was admitted to hospital becuase of urinary frequency,urgency and gross hematuria for more than one month.Laboratory examination,ultrasound,CT,cystoscopy,urine culture and biopsy were preformed.Bladder water expansion,bladder mucosal protective agent perfusion,anti-infective treatment and other comprehensive treatment were applied.The patient were followed up for three mouths after discharging.Result:CT showed severe contracture of bladder and significant thickening of bladder.Transurethral cystoscopy showed a significant reduction of bladder capacity and a " white lime"-like change in the bladder mucosa.The results of seven-time urine culture were all multiple drug resistance Myroides odoratimimus.After treatment,the clinical symptoms improved significantly,the bladder volume returned to normal,urine culture results were normal,CT and cystoscopy review improved significantly.Conclusion:Urinary culture and cystoscopy combined with pathologic examination can improve the diagnosis rate of patients with bladder contracture.The urinary tract infection of Myroides odoratimimus is rare.Severe contracture of bladder combined with Myroides odoratimimus infection has never been reported.The comprehensive treatment may obtain satisfactory results.
作者 陈国晓 张祥生 丁德刚 范志强 王山梅 张付华 张士龙 刘洁 郭应禄 CHEN Guoxiao;ZHANG Xiangsheng;DING Degang;FAN Zhiqiang;WANG Shanmei;ZHANG Fuhua;ZHANG Shilong;LIU Jie;GUO Yinglu(Department of Urology, Henan Provincial People' s Hospital&People' s Hospital of Zhengzhou University, Zhengzhou, 450003, China;Department of Clinical Laboratory, Henan Provincial People's Hospital~People's Hospital of Zhengzhou University;Department of Infection Management, Henan Provincial People' s Hospital&People' s Hospital of Zhengzhou University;Department of Urology, Peking University First Hospital, Institute of Urology, Peking University)
出处 《临床泌尿外科杂志》 2018年第6期486-490,共5页 Journal of Clinical Urology
基金 河南省自然科学基金资助项目(编号162300410309) 河南省男科学基础与临床研究院士工作站基金资助(编号豫科[2010]104号)
关键词 膀胱挛缩 香味类香味菌 慢性膀胱炎 多重耐药 bladder contracture Myroides odoratimimus chronic cystitis multiple drug resistance
  • 相关文献

参考文献4

二级参考文献31

  • 1严秋哲 杨勇 朱绪辉 等.麻醉下水扩张诊断间质性膀胱炎[J].中华泌尿外科杂志,2007,28(11):756-758.
  • 2Hanno P, Nordling J, van Ophoven A. What is new in bladder pain syndrome/interstitial cystitis?. Curr Opin Urol, 2008, 18 353-358.
  • 3O'Leary MP, Sant GR, Fowler FJ Jr, et al. The interstitial cysti- tis symptom index and problem index. Urology, 1997, 49: 58- 63.
  • 4Ericksona DR, Kunselman AR, Bentley CM, et al. Changes in urine markers and symptoms after bladder distention for intersti- tial cystitis. J Urol, 2007, 177: 556-560.
  • 5Namazi H. Intravesical botulinum toxin A injections plus hydro- distension can reduce nerve growth factor production and control bladder pain in interstitial cystitis : a molecular mechanism. Urol- ogy, 2008, 72 : 463-464.
  • 6Seth A, Teichman JM. What's new in the diagnosis and manage- ment of painful bladder syndrome/interstitial cystitis?. Curr Urol Rep, 2008, 9: 349-357.
  • 7Berry SH, Bogart LM, Pham C, et al. Development, validation and testing of an epidemiological case de.finition of interstitial cys- titis/painful bladder syndrome. J Urol, 2010, 183 : 1848-1852.
  • 8Aihara K, Hirayama A, Tanaka N, et al. Hydrodistension under local anesthesia for patients with suspected painful bladder syn- drome/interstitial cystitis : safety, diagnostic potential and thera- peutic efficacy. Int J Urol, 2009, 16 : 947-952.
  • 9Parsons CL. The potassium sensitivity test: a new gold standard for diagnosing and understanding the pathophysiology of intersti- tial cystitis. J Urol, 2009, 182: 432-434.
  • 10Mammeri H, Bellais S, Nordmann P. Chromosome-encoded beta- lactamases TUS-1 and MUS-1 from Myroides odoratus and Myroides odoratimimus (formerly Flavobacterium odoratum) , new members of the lineage of molecular subclass B1 metalloenzymes[J]. Antimicrob Agents Chemother, 2002, 46(11): 3561-3567.

共引文献33

同被引文献12

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部